TOWER HOUSE PRACTICE — All Prescriptions & Medications — Page 2
Practice Code: N81057 | RUNCORN, WA7 1AB
Showing results 51-100 of 649
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Macrogol 3350 | 1,344 | 79.7K | £12.6K | +43.3% ▲ |
| Bendroflumethiazide | 1,304 | 55.3K | £886 | +68.6% ▲ |
| Allopurinol | 1,258 | 67.7K | £1.5K | +22.0% ▲ |
| Fluoxetine hydrochloride | 1,226 | 59.9K | £3.0K | +20.9% ▲ |
| Doxazosin mesilate | 1,222 | 86.4K | £3.3K | +14.4% ▲ |
| Edoxaban | 1,210 | 40.5K | £67.4K | +72.7% ▲ |
| Duloxetine hydrochloride | 1,207 | 36.6K | £6.5K | +89.9% ▲ |
| Doxycycline hyclate | 1,191 | 15.1K | £1.3K | +132.3% ▲ |
| Montelukast | 1,182 | 37.3K | £1.9K | +72.6% ▲ |
| Carbocisteine | 1,177 | 186.4K | £6.1K | +120.5% ▲ |
| Hydrocortisone | 1,162 | 42.1K | £8.5K | +159.1% ▲ |
| Thiamine hydrochloride | 1,137 | 64.9K | £1.9K | +115.7% ▲ |
| Solifenacin | 1,124 | 43.2K | £2.1K | +135.6% ▲ |
| Glucose blood testing reagents | 1,043 | 102.7K | £17.4K | +32.2% ▲ |
| Codeine phosphate | 1,039 | 94.7K | £3.3K | +44.6% ▲ |
| Gliclazide | 1,027 | 72.3K | £2.2K | +20.7% ▲ |
| Oxycodone hydrochloride | 1,016 | 76.9K | £16.0K | +297.0% ▲ |
| Finasteride | 1,012 | 36.1K | £1.3K | +54.5% ▲ |
| Senna | 988 | 51.6K | £1.2K | +64.2% ▲ |
| Latanoprost | 988 | 12.4K | £5.1K | +103.5% ▲ |
| 979 | 131.7K | £5.4K | +106.3% ▲ | |
| Sildenafil (Erectile Dysfunction) | 963 | 5,054 | £701 | +91.1% ▲ |
| Atenolol | 953 | 42.0K | £909 | +58.1% ▲ |
| Empagliflozin | 936 | 29.6K | £36.8K | +49.6% ▲ |
| Rosuvastatin calcium | 923 | 29.8K | £875 | +2.8% ▲ |
| Lactulose | 914 | 509.0K | £4.8K | +177.6% ▲ |
| Ezetimibe | 898 | 29.9K | £5.2K | +26.2% ▲ |
| Estradiol | 898 | 86.9K | £12.2K | +9.4% ▲ |
| Warfarin sodium | 892 | 41.5K | £1.4K | +89.2% ▲ |
| Spironolactone | 889 | 28.0K | £3.4K | +64.9% ▲ |
| Hyoscine butylbromide | 881 | 94.9K | £6.5K | +278.0% ▲ |
| Lamotrigine | 855 | 60.1K | £8.5K | +44.8% ▲ |
| 842 | 916 | £40.6K | +171.1% ▲ | |
| Ibuprofen | 841 | 84.2K | £3.0K | +65.3% ▲ |
| Desogestrel | 839 | 79.7K | £3.4K | +111.7% ▲ |
| Mometasone furoate | 838 | 923 | £7.1K | +108.7% ▲ |
| Candesartan cilexetil | 837 | 31.9K | £1.8K | -29.5% ▼ |
| Betamethasone valerate | 811 | 68.1K | £4.0K | +110.6% ▲ |
| Sumatriptan succinate | 800 | 8,006 | £3.3K | +125.9% ▲ |
| Methotrexate | 793 | 15.9K | £9.6K | +143.6% ▲ |
| Nitrofurantoin | 792 | 10.6K | £6.0K | +66.0% ▲ |
| Famotidine | 789 | 32.2K | £18.5K | +61.7% ▲ |
| 776 | 89.3K | £6.1K | +258.8% ▲ | |
| Ranolazine | 766 | 47.9K | £8.7K | +350.7% ▲ |
| Docusate sodium | 753 | 69.6K | £4.9K | +103.1% ▲ |
| Flucloxacillin sodium | 745 | 32.8K | £1.8K | +65.7% ▲ |
| Tirzepatide | 737 | 742 | £69.4K | +279.5% ▲ |
| Mebeverine hydrochloride | 731 | 64.1K | £9.2K | +135.4% ▲ |
| Buspirone hydrochloride | 716 | 49.1K | £6.1K | +1,321.2% ▲ |
| Co-dydramol (Dihydrocodeine/paracetamol) | 716 | 83.7K | £4.2K | +298.5% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.